- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有8家主力机构披露2025-12-31报告期持股数据，持仓量总计153.11万股，占流通A股0.08%
- 波段诊断：
-
技术面诊股
诊断结果：2.6技术面打败了5%的股票
技术面评分前10的股票
近期的平均成本为8.76元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为8.76元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.76","date":1770884158,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.02.13","stock":"-0.57","trade":"-0.55","ind":"-1.26"},{"date":"2026.02.12","stock":"-1.13","trade":"-0.47","ind":"0.05"},{"date":"2026.02.11","stock":"-0.23","trade":"-0.58","ind":"0.09"},{"date":"2026.02.10","stock":"-0.22","trade":"0.30","ind":"0.13"},{"date":"2026.02.09","stock":"-0.22","trade":"0.78","ind":"1.41"},{"date":"2026.02.06","stock":"-0.89","trade":"0.22","ind":"-0.25"},{"date":"2026.02.05","stock":"3.33","trade":"-0.38","ind":"-0.64"},{"date":"2026.02.04","stock":"0.35","trade":"0.70","ind":"0.85"},{"date":"2026.02.03","stock":"1.17","trade":"1.66","ind":"1.29"},{"date":"2026.02.02","stock":"-5.30","trade":"-2.66","ind":"-2.48"},{"date":"2026.01.30","stock":"2.61","trade":"-1.26","ind":"-0.96"},{"date":"2026.01.29","stock":"-1.89","trade":"-1.58","ind":"0.16"},{"date":"2026.01.28","stock":"-1.10","trade":"-2.31","ind":"0.27"},{"date":"2026.01.27","stock":"0.11","trade":"-0.80","ind":"0.18"},{"date":"2026.01.26","stock":"2.02","trade":"3.60","ind":"-0.09"},{"date":"2026.01.23","stock":"0.79","trade":"1.33","ind":"0.33"},{"date":"2026.01.22","stock":"0.34","trade":"-0.59","ind":"0.14"},{"date":"2026.01.21","stock":"-0.11","trade":"0.19","ind":"0.08"},{"date":"2026.01.20","stock":"2.20","trade":"-0.83","ind":"-0.01"},{"date":"2026.01.19","stock":"1.41","trade":"0.05","ind":"0.29"},{"date":"2026.01.16","stock":"-0.70","trade":"-0.86","ind":"-0.26"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为8.74元，支撑位为8.65元。
[{"text":"\u538b\u529b\u4f4d","value":"8.74","date":1770912000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.65","date":1770912000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.7资金面打败了2%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：02月16日 20:31
| 机构今日流向(万元) | -2071.13 | 机构5日流向(万元) | -6008.35 |
| 机构10日流向(万元) | -10093.82 | 机构20日流向(万元) | -23967.11 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少97204.98万股，其中基金数没有增加，主力净减仓249家，请投资者中长期谨慎为宜。
截止2025-12-31，共8家主力机构（基金8家），持仓量总计153.11万股，占流通A股0.08%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：8家 ，持有153.11万股
从主力名单中消失：257家 ，原持有97358.09万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：8家 ，持有153.11万股
从主力名单中消失：257家 ，原持有97358.09万股
消息面诊股
诊断结果：5.5消息面打败了57%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 通化东宝：2月12日获融资买入1763.39万元
2026-02-13 - 通化东宝：2月11日获融资买入1596.96万元
2026-02-12 - 通化东宝：2月10日获融资买入1781.99万元
2026-02-11 - 通化东宝就房产混用情况完成整改
2026-02-10 - 通化东宝：2月9日获融资买入1988.83万元
2026-02-10 - 创新药+脑机接口+AI 医疗，最值得长期跟踪的10
2026-02-09 - 震荡行情如何选基金?年报预喜股藏玄机
2026-02-07 - 通化东宝：2月6日获融资买入3045.01万元
2026-02-07 - 【市场】51款新药拟进院，独家品种霸屏
2026-02-06 - GLP-1类药物成全球新药“销冠” 国内多家上市公
2026-02-05
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-01-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-31 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-31 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-29 |
| 一般消息 | 高管变动 | 公司内部工作调整 | 2025-11-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 因工作安排调整 | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-26 |
| 一般消息 | 高管变动 | 个人原因 | 2025-07-04 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-09 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-03-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-20 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.3行业面打败了75%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.02.13","price":"-1.26","value":"-0.55"},{"date":"2026.02.12","price":"0.05","value":"-0.47"},{"date":"2026.02.11","price":"0.09","value":"-0.58"},{"date":"2026.02.10","price":"0.13","value":"0.30"},{"date":"2026.02.09","price":"1.41","value":"0.78"},{"date":"2026.02.06","price":"-0.25","value":"0.22"},{"date":"2026.02.05","price":"-0.64","value":"-0.38"},{"date":"2026.02.04","price":"0.85","value":"0.70"},{"date":"2026.02.03","price":"1.29","value":"1.66"},{"date":"2026.02.02","price":"-2.48","value":"-2.66"},{"date":"2026.01.30","price":"-0.96","value":"-1.26"},{"date":"2026.01.29","price":"0.16","value":"-1.58"},{"date":"2026.01.28","price":"0.27","value":"-2.31"},{"date":"2026.01.27","price":"0.18","value":"-0.80"},{"date":"2026.01.26","price":"-0.09","value":"3.60"},{"date":"2026.01.23","price":"0.33","value":"1.33"},{"date":"2026.01.22","price":"0.14","value":"-0.59"},{"date":"2026.01.21","price":"0.08","value":"0.19"},{"date":"2026.01.20","price":"-0.01","value":"-0.83"},{"date":"2026.01.19","price":"0.29","value":"0.05"},{"date":"2026.01.16","price":"-0.26","value":"-0.86"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 44.16% | 13.39% | 5.9分 |
| 2 | 卫光生物 | 19.11% | 5.76% | 6.0分 |
| 3 | 诺诚健华 | 9.75% | 0.75% | 6.1分 |
| 4 | 欧林生物 | 9.62% | 15.01% | 6.2分 |
| 5 | 华兰疫苗 | 9.61% | -4.20% | 4.0分 |
| 6 | 赛伦生物 | 5.38% | 1.92% | 5.9分 |
| 8 | *ST四环 | 2.80% | -1.53% | 5.8分 |
| 10 | 通化东宝 | 2.35% | -2.36% | 4.3分 |
| 12 | 赛升药业 | -0.27% | -0.79% | 6.0分 |
| 14 | 东宝生物 | -0.65% | 0.16% | 5.6分 |
| 16 | - | -0.98% | -1.66% | 分 |
| 18 | 康辰药业 | -1.13% | -2.00% | 6.3分 |
| 20 | 百克生物 | -3.08% | -2.59% | 4.4分 |
| 22 | 昊帆生物 | -3.84% | -3.73% | 4.2分 |
| 24 | 沃森生物 | -4.39% | -3.31% | 4.0分 |
| 26 | 西藏药业 | -4.68% | -2.41% | 5.2分 |
| 28 | 诺唯赞 | -4.90% | -0.53% | 5.2分 |
| 30 | - | -5.21% | -7.18% | 分 |
| 32 | 博雅生物 | -5.39% | -1.92% | 4.1分 |
| 34 | 百奥泰 | -5.46% | 0.08% | 5.7分 |
| 36 | 博晖创新 | -5.87% | -2.80% | 4.1分 |
| 38 | 君实生物 | -7.00% | -1.81% | 4.7分 |
| 40 | 近岸蛋白 | -7.29% | -0.50% | 4.4分 |
| 42 | 义翘神州 | -7.54% | -0.10% | 4.9分 |
| 44 | - | -9.53% | -1.56% | 分 |
| 46 | 智飞生物 | -10.68% | -3.26% | 4.3分 |
| 48 | 长春高新 | -12.09% | -3.20% | 3.7分 |
| 50 | 康弘药业 | -14.46% | -1.44% | 4.8分 |
| 52 | 神州细胞 | -16.37% | -1.55% | 4.5分 |
| 54 | 凯因科技 | -18.65% | -0.37% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 3/71 ， 29/71。
[{"date":"2025-09-30","value":"17.80","vol":"-9.78"},{"date":"2025-06-30","value":"3.48","vol":"-0.61"},{"date":"2025-03-31","value":"1.70","vol":"0.46"},{"date":"2024-12-31","value":"-0.63","vol":"-0.68"},{"date":"2024-09-30","value":"-0.97","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.80 | 3.48 | 1.70 | -0.63 | -0.97 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"71.89","vol":"67.61"},{"date":"2025-06-30","value":"71.45","vol":"68.28"},{"date":"2025-03-31","value":"69.32","vol":"68.43"},{"date":"2024-12-31","value":"73.90","vol":"69.85"},{"date":"2024-09-30","value":"74.47","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
71.89 | 71.45 | 69.32 | 73.90 | 74.47 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，居行业前列，两项指标的行业排名分别为 7/71 ， 1/71。
[{"date":"2025-09-30","value":"50.55","vol":"45.25"},{"date":"2025-06-30","value":"85.60","vol":"6902.04"},{"date":"2025-03-31","value":"10.17","vol":"6125.27"},{"date":"2024-12-31","value":"-34.66","vol":"47.35"},{"date":"2024-09-30","value":"-30.78","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
50.55 | 85.60 | 10.17 | -34.66 | -30.78 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1911.35","vol":"44.80"},{"date":"2025-06-30","value":"194.48","vol":"5.44"},{"date":"2025-03-31","value":"-49.15","vol":"-8.46"},{"date":"2024-12-31","value":"-103.66","vol":"-9.81"},{"date":"2024-09-30","value":"-108.73","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
1911.35 | 194.48 | -49.15 | -103.66 | -108.73 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 16/71 ， 19/71。
[{"date":"2025-09-30","value":"0.28","vol":"0.22"},{"date":"2025-06-30","value":"0.18","vol":"0.14"},{"date":"2025-03-31","value":"0.09","vol":"0.06"},{"date":"2024-12-31","value":"0.27","vol":"0.29"},{"date":"2024-09-30","value":"0.19","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.18 | 0.09 | 0.27 | 0.19 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.83","vol":"0.92"},{"date":"2025-06-30","value":"0.53","vol":"0.56"},{"date":"2025-03-31","value":"0.27","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.17"},{"date":"2024-09-30","value":"0.50","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.83 | 0.53 | 0.27 | 0.73 | 0.50 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"7.80","vol":"1.84"},{"date":"2025-06-30","value":"30.25","vol":"-1377.61"},{"date":"2025-03-31","value":"15.19","vol":"-46.99"},{"date":"2024-12-31","value":"41.76","vol":"-11.33"},{"date":"2024-09-30","value":"13.70","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.80 | 30.25 | 15.19 | 41.76 | 13.70 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.97","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.77","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.97 | - | 2.77 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 35/71 ， 36/71。
[{"date":"2025-09-30","value":"4.64","vol":"6.00"},{"date":"2025-06-30","value":"1.76","vol":"6.64"},{"date":"2025-03-31","value":"2.89","vol":"7.75"},{"date":"2024-12-31","value":"3.02","vol":"6.72"},{"date":"2024-09-30","value":"4.30","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.64 | 1.76 | 2.89 | 3.02 | 4.30 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.38","vol":"4.84"},{"date":"2025-06-30","value":"1.17","vol":"5.30"},{"date":"2025-03-31","value":"1.72","vol":"6.35"},{"date":"2024-12-31","value":"1.80","vol":"5.40"},{"date":"2024-09-30","value":"2.32","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.38 | 1.17 | 1.72 | 1.80 | 2.32 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 36/71 ， 36/71。
[{"date":"2025-09-30","value":"12.46","vol":"28.18"},{"date":"2025-06-30","value":"21.80","vol":"26.73"},{"date":"2025-03-31","value":"13.73","vol":"26.03"},{"date":"2024-12-31","value":"13.26","vol":"25.81"},{"date":"2024-09-30","value":"9.74","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.46 | 21.80 | 13.73 | 13.26 | 9.74 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.14","vol":"0.58"},{"date":"2025-06-30","value":"0.28","vol":"1.11"},{"date":"2025-03-31","value":"0.16","vol":"0.78"},{"date":"2024-12-31","value":"0.15","vol":"0.87"},{"date":"2024-09-30","value":"0.11","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.28 | 0.16 | 0.15 | 0.11 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.08","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.43","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.27","blueLineValue":"0.47","type":"YC"}]